Page last updated: 2024-08-24

lathosterol and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid

lathosterol has been researched along with (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Angelin, B; Davis, MA; Einarsson, C; Eriksson, M; Gustafsson, U; Larsson, L; Omura, S; Parini, P; Rudel, LL; Rudling, M; Sahlin, S; Tomoda, H; Wilson, M1
Gylling, H; Miettinen, TA; Miettinen, TE; Nissinen, MJ1
Abe, S; Inoue, T; Node, K; Sakuma, M; Taguchi, I; Toyoda, S1

Trials

3 trial(s) available for lathosterol and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid

ArticleYear
Cholesterol synthesis inhibition elicits an integrated molecular response in human livers including decreased ACAT2.
    Arteriosclerosis, thrombosis, and vascular biology, 2008, Volume: 28, Issue:6

    Topics: Apolipoproteins E; Atorvastatin; Biopsy; Cholesterol; Cholesterol, VLDL; Fatty Acids, Monounsaturated; Female; Fluvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Liver; Male; Middle Aged; Pyrroles; Receptors, LDL; RNA, Messenger; Sterol O-Acyltransferase; Sterol O-Acyltransferase 2

2008
Applicability of non-cholesterol sterols in predicting response in cholesterol metabolism to simvastatin and fluvastatin treatment among hypercholesterolemic men.
    Nutrition, metabolism, and cardiovascular diseases : NMCD, 2010, Volume: 20, Issue:5

    Topics: Cholestanol; Cholesterol; Desmosterol; Double-Blind Method; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Indoles; Lipids; Male; Middle Aged; Simvastatin; Sterols

2010
Inhibition of intestinal cholesterol absorption might explain cholesterol-lowering effect of telmisartan.
    Journal of clinical pharmacy and therapeutics, 2011, Volume: 36, Issue:1

    Topics: Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Anticholesteremic Agents; Benzimidazoles; Benzoates; Biomarkers; Cholestanol; Cholesterol; Cholesterol, LDL; Fatty Acids, Monounsaturated; Female; Fluvastatin; Gastrointestinal Agents; Humans; Hypercholesterolemia; Hypertension; Indoles; Intestinal Absorption; Male; Middle Aged; PPAR gamma; Telmisartan

2011